According to OpenAI, GPT-5 was connected to Ginkgo’s autonomous lab to propose experiments, run them at scale, learn from outcomes, and decide subsequent iterations in a closed loop, resulting in a reported 40% reduction in protein production costs (source: OpenAI). For traders, the claim highlights accelerating AI-driven lab automation and synthetic biology efficiency that could influence biomanufacturing economics and demand for AI infrastructure and lab automation software if reproduced at scale (underlying facts source: OpenAI).